UNSPSC 51461509: Primula

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifiers W6LFQ57E4M and TA94NTR55X (root), O2OYX71E94 (leaf), and W5BET37294 (flower), the source of which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 24035 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Asteranae, Order Ericales, Family Primulaceae (primroses), Genus Primula L. (shootingstar, primrose), Species Primula veris L., commonly known as cowslip primrose or as here, primula.

UNSPSC 51461509 Primula, a Commodity code, encompasses generic multi-source pharmaceuticals and over-the-counter products that state and local procurement bodies purchase through cooperative purchasing arrangements. The work involves manufacturing and pricing pharmaceutical products for distribution to state and local government facilities, requiring vendors to maintain compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. State and local agencies participating in cooperative purchasing vehicles — particularly multistate alliances — use this code to procure standardized pharmaceutical inventories through authorized wholesale distributors rather than direct procurement. Issuing bodies include state departments of administration and procurement offices that administer cooperative purchasing programs serving multiple state and local member jurisdictions.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued the primary recent opportunity under this code: a Request for Proposal (RFP) posted January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products. The solicitation covers Minnesota, Oregon, and other participating member jurisdictions. MMCAP requires vendors to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and maintains contractual relationships with at least two of the three. Evaluation emphasizes price competitiveness at 75 percent, with remaining weight distributed among fixed pricing, administrative compliance, EDI capability, and willingness to accept a 3 percent administrative fee. The resulting contracts take effect July 1, 2026, with a two-year initial term and optional extensions at MMCAP's discretion.